Also trades as: ZLD.AX (ASX) · $vol 0M
ZLDAF OTC
Zelira Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: -25.7%
YTD: -4.3%
1Y: -1.4%
3Y: -52.7%
5Y: -96.1%
$0.26
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1M
-74.9% ▼
5Y CAGR: -48.5%
Total Liabilities
$6M
-40.2% ▼
5Y CAGR: +35.1%
Shareholders Equity
-$4M
+1.2% ▲
Cash & Investments
$6K
-99.0% ▼
5Y CAGR: -68.0%
Total Debt
$2M
-64.0% ▼
5Y CAGR: +27.6%
Net Debt
$2M
-60.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5M | $3M | $146K | $586K | $6K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $5M | $3M | $146K | $586K | $6K |
| Net Receivables | $57K | $256K | -$1K | $198K | $5K |
| Inventory | $868K | $2M | $2M | $1M | $478K |
| Other Current Assets | $0 | $0 | $0 | $2M | $28K |
| Total Current Assets | $6M | $5M | $2M | $4M | $614K |
| Property, Plant & Equip. | $1M | $848K | $519K | $225K | $122K |
| Goodwill & Intangibles | $63M | $62M | $62M | $655K | $521K |
| Long-Term Investments | $167K | $64K | $43K | $43K | $0 |
| Other Non-Current Assets | -$33M | -$33M | -$32M | $0 | $44K |
| Total Non-Current Assets | $33M | $33M | $32M | $923K | $686K |
| Total Assets | $39M | $38M | $34M | $5M | $1M |
| — Liabilities — | |||||
| Accounts Payable | $985K | $2M | $2M | $3M | $3M |
| Short-Term Debt | $0 | $0 | $0 | $4M | $2M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $1M | $2M | $2M | $7M | $6M |
| Long-Term Debt | $0 | $0 | $0 | $2M | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $461K | $384K | $295K | $2M | $0 |
| Total Liabilities | $2M | $2M | $2M | $9M | $6M |
| — Equity — | |||||
| Common Stock | $37M | $44M | $46M | $46M | $46M |
| Retained Earnings | -$27M | -$39M | -$45M | -$81M | -$85M |
| Accumulated OCI | $28M | $31M | $31M | $31M | $35M |
| Total Stockholders Equity | $38M | $35M | $32M | -$5M | -$4M |
| Total Liabilities & Equity | $39M | $38M | $34M | $5M | $1M |
| — Key Metrics — | |||||
| Total Debt | $551K | $501K | $438K | $6M | $2M |
| Net Debt | -$4M | -$2M | $292K | $5M | $2M |
| Total Investments | $167K | $64K | $43K | $43K | $0 |